
Cetuximab 100 mg/20 mL (Cetuxa) is a targeted anticancer medicine used to treat EGFR-expressing colorectal cancer and head and neck squamous cell carcinoma. It is administered as an intravenous infusion under medical supervision. Cetuximab works by blocking signals that promote cancer cell growth and spread, helping improve treatment outcomes.
| Generic name | Cetuximab |
| Strength | 100 mg |
| Manufacturer | ALKEM LABORATORIES |
| Package size | 1 vial of 20 ml |
| Used for | Metastatic colorectal cancer and head and neck squamous cell carcinoma |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Cetuximab is a monoclonal antibody that targets the epidermal growth factor receptor (EGFR) on cancer cells. By blocking EGFR, it prevents signals that promote cancer cell growth and division, helping slow tumour growth and spread.
Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.